Overall rank by patents
#31,353
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, D3D ranks #31,353 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.
USPTO PatentsView assignee plate
Corpus R31353 · US Corporation #31,353 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: CytoVeris, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Cequence Security · near
31 score
D3D · this assignee
31 score
dbest products · near
31 score
Ariat International · near
31 score
The Dial · near
31 score
3D Lighting… · lowest
7 score
What this shows D3D's Innovation Score is 31.0/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
D3D Technologies, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (4 grants) versus a trough of 1 in 2020. By volume, D3D sits between CytoVeris, Inc. and DAP Realize Inc..
D3D Technologies, Inc. shows 1 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CytoVeris, Inc.
8 patents
D Three Enterprises, LLC
8 patents
D&R Tech LLC
8 patents
D. LA Porte SÖHNE GMBH
8 patents
Daeyoung Chaevi Co., Ltd.
8 patents
Daiken Medical Co., Ltd.
8 patents
Dalian University
8 patents
DAP Realize Inc.
8 patents
D3D Technologies, Inc.
8 patents
What this shows D3D holds 8 patents at rank #31,354, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #31,354 in granted patent volume.
Other assignees with the most granted patents in D3D's primary technology class.
Two PlainPatent-derived peer sets for D3D, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (31 here).
D3D's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 36th percentile higher than 36% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 12.5% |
| 2021 | 4 | 50.0% |
| 2022 | 1 | 12.5% |
| 2025partial year | 2 | 25.0% |
Top 4 of 4 technology areas
Overall rank by patents
#31,353
of 49,997 tracked assignees
31.0 out of 100
What to do with this data
D3D Technologies, Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.